Rise Advisors, LLC: C position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rise Advisors, LLC on C, newest first. How the timeline and the estimate are built.
Rise Advisors, LLC held 0 C shares at 2025-12-31 per its 13F-HR filed 2026-02-11.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -1,131 shares
13F-HR 0001831316-26-000001 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 1,131 sharesChange vs previous 13F -6,965 shares
0.04% of the 13F portfolio, value $114,802.
13F-HR 0001831316-25-000007 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 8,096 sharesChange vs previous 13F +7,008 shares
0.27% of the 13F portfolio, value $689,099.
13F-HR 0001831316-25-000006 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,088 sharesChange vs previous 13F +91 shares
0.03% of the 13F portfolio, value $77,246.
13F-HR 0001831316-25-000005 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 997 sharesChange vs previous 13F -93 shares
0.03% of the 13F portfolio, value $70,186.
13F-HR 0001831316-25-000001 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,090 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $68,235.
13F-HR 0001831316-24-000004 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).